Alpha confirmed that until further notice it would 'not be using the cryoprecipitated material from plasma from hepatitis B surface antibody donors in the manufacture of Antihemophilic Factor (Human).'
Chronology Information
Date:
Chapter/issue
Blood Products and Addressing Risk: Regulation of Commercial Factor Concentrates
Key Person(s)
Marietta Carr (Penny)